These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10067682)

  • 21. Evidence for specificity in type 4 pilus biogenesis by enteropathogenic Escherichia coli.
    McNamara BP; Donnenberg MS
    Microbiology (Reading); 2000 Mar; 146 ( Pt 3)():719-729. PubMed ID: 10746776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoactivation and environmental regulation of bfpT expression, the gene coding for the transcriptional activator of bfpA in enteropathogenic Escherichia coli.
    Martínez-Laguna Y; Calva E; Puente JL
    Mol Microbiol; 1999 Jul; 33(1):153-66. PubMed ID: 10411732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli.
    Girón JA; Qadri F; Azim T; Jarvis KJ; Kaper JB; Albert MJ
    Infect Immun; 1995 Dec; 63(12):4949-52. PubMed ID: 7591164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bundle-forming pili of enteropathogenic Escherichia coli: transcriptional regulation by environmental signals.
    Puente JL; Bieber D; Ramer SW; Murray W; Schoolnik GK
    Mol Microbiol; 1996 Apr; 20(1):87-100. PubMed ID: 8861207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.
    Chen H; Schifferli DM
    Infect Immun; 2003 Aug; 71(8):4664-73. PubMed ID: 12874347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.
    Dougan G; Hormaeche CE; Maskell DJ
    Parasite Immunol; 1987 Mar; 9(2):151-60. PubMed ID: 3106921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein.
    Poirier TP; Kehoe MA; Beachey EH
    J Exp Med; 1988 Jul; 168(1):25-32. PubMed ID: 3294331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine.
    Khursigara C; Abul-Milh M; Lau B; Girón JA; Lingwood CA; Barnett Foster DE
    Infect Immun; 2001 Nov; 69(11):6573-9. PubMed ID: 11598024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo properties of a cloned K88 adherence antigen determinant.
    Dougan G; Sellwood R; Maskell D; Sweeney K; Liew FY; Beesley J; Hormaeche C
    Infect Immun; 1986 Apr; 52(1):344-7. PubMed ID: 2870029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.
    Guzmán CA; Brownlie RM; Kadurugamuwa J; Walker MJ; Timmis KN
    Infect Immun; 1991 Dec; 59(12):4391-7. PubMed ID: 1937797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of recombinant bacillus Calmette-Guérin and Mycobacterium smegmatis expressing BfpA and intimin as vaccine vectors against enteropathogenic Escherichia coli.
    Vasconcellos HL; Scaramuzzi K; Nascimento IP; Da Costa Ferreira JM; Abe CM; Piazza RM; Kipnis A; Dias da Silva W
    Vaccine; 2012 Sep; 30(41):5999-6005. PubMed ID: 22828590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice.
    Brown A; Hormaeche CE; Demarco de Hormaeche R; Winther M; Dougan G; Maskell DJ; Stocker BA
    J Infect Dis; 1987 Jan; 155(1):86-92. PubMed ID: 3098864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model.
    Breau C; Cameron DW; Desjardins M; Lee BC
    J Immunol Methods; 2012 Jan; 375(1-2):232-42. PubMed ID: 22100216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.
    Maskell DJ; Sweeney KJ; O'Callaghan D; Hormaeche CE; Liew FY; Dougan G
    Microb Pathog; 1987 Mar; 2(3):211-21. PubMed ID: 3333799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB.
    Quintana Flores VM; Campos de Souza Fernandes RC; Sousa de Macedo Z; Medina-Acosta E
    Protein Expr Purif; 2002 Jun; 25(1):16-22. PubMed ID: 12071694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.